Although there are some experimental skin patches where GLP-1 agonist medicines like semaglutide are used as active ingredients, these are still under trial and not yet approved for use
Metabolic Pharmaceuticals Pty Ltd, an Australian biotechnology company, licensed the Monash intellectual property and set out to produce a more stable analogue suitable for administration studies
The BK channel opener BMS-191011 was shown to suppress behavioral evidence of salicylate-induced tinnitus in mice, with local application in the inferior colliculus reversing salicylate-suppressed spontaneous activity, particularly in the frequency region corresponding to the tinnitus percept, highlighting a key site of action see in Figure 2 - (Scott et al., 2022)
This may be a reason why there is no association between PyroGlu and clinical severity parameters
showed that nitration of mitochondrial proteins and depletion of mitochondrial DNA after acetaminophen overdose in mice was due to peroxynitrite formation